Stem cell companies are often in the headlines, with many aspects of the work debated publicly. With this spotlight consistently on their business, managers must take care that all rules governing their processes are strictly adhered to. If they aren't, there could be a public backlash that would affect the business and its clients. An employee of a stem cell company said that he brought such problems to bosses and was fired. In response, he filed a wrongful termination claim.
The stem cell company gets millions of dollars of funding from the government. That amount includes grant money paid by the California Institute for Regenerative Medicine. The money comes with the condition that the company will follow strict manufacturing processes. Indeed, according to the complaint filed in the case, the company contends that its processes are what they need to be to produce stem cells that are safe for transplantation.